A higher expression of ACE2 predicted better outcomes for disease-free survival and overall survival in tumours such as renal clear cell carcinoma, hepatocellular carcinoma, and ovarian serous cystadenocarcinoma [7]. Here, ACE2 is linked to clear cell renal carcinoma.